title: Acute encephalopathy associated with influenza and other viral infections.
abstract: Acute encephalopathy is the most serious complication of pediatric viral infections, such as influenza and exanthem subitum. It occurs worldwide, but is most prevalent in East Asia, and every year several hundreds of Japanese children are affected by influenza-associated encephalopathy. Mortality has recently declined, but is still high. Many survivors are left with motor and intellectual disabilities, and some with epilepsy. This article reviews various syndromes of acute encephalopathy by classifying them into three major categories. The first group caused by metabolic derangement consists of various inherited metabolic disorders and the classical Reye syndrome. Salicylate is a risk factor of the latter condition. The second group, characterized by a systemic cytokine storm and vasogenic brain edema, includes Reye-like syndrome, hemorrhagic shock and encephalopathy syndrome, and acute necrotizing encephalopathy. Non-steroidal anti-inflammatory drugs, such as diclofenac sodium and mephenamic acid, may aggravate these syndromes. Severe cases are complicated by multiple organ failure and disseminated intravascular coagulation. Mortality is high, although methylprednisolone pulse therapy may be beneficial in some cases. The third group, characterized by localized edema of the cerebral cortex, has recently been termed acute encephalopathy with febrile convulsive status epilepticus, and includes hemiconvulsion-hemiplegia syndrome and acute infantile encephalopathy predominantly affecting the frontal lobes. Theophylline is a risk factor of these syndromes. The pathogenesis is yet to be clarified, but an increasing body of evidence points to excitotoxicity and delayed neuronal death.
authors.affiliation: Department of Pediatrics, Graduate School of Medicine, University of Tokyo, Tokyo, Japan. mizuguchi-tky@umin.ac.jp
authors.forename: M
authors.initials: M
authors.lastname: Mizuguchi
authors.forename: H
authors.initials: H
authors.lastname: Yamanouchi
authors.forename: T
authors.initials: T
authors.lastname: Ichiyama
authors.forename: M
authors.initials: M
authors.lastname: Shiomi
mesh_terms: D000893:Anti-Inflammatory Agents / Q000009:adverse effects; D001921:Brain / Q000187:drug effects / Q000503:physiopathology* / Q000821:virology*; D001928:Brain Diseases, Metabolic / Q000209:etiology / Q000276:immunology / Q000503:physiopathology*; D001929:Brain Edema / Q000276:immunology / Q000503:physiopathology* / Q000821:virology; D002648:Child; D002675:Child, Preschool; D006801:Humans; D007223:Infant; D007251:Influenza, Human / Q000150:complications; D003294:Seizures, Febrile / Q000276:immunology / Q000503:physiopathology* / Q000821:virology; D013806:Theophylline / Q000009:adverse effects; D014777:Virus Diseases / Q000150:complications*